← Back to all trials
Not Yet Recruiting
NCT06637839
Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
Conditions: Stroke
Sex: All
Ages: 18 Years – 95 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: NYU Langone Health
Location: NYU Langone Health New York New York
Summary
The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery.
This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Eligibility Criteria
Inclusion Criteria:
• Primary diagnosis of stroke
Exclusion Criteria:
* Weightbearing restrictions, uncontrolled cardiopulmonary, metabolic, infectious, or psychiatric disorders, which would preclude aerobic locomotor training
* Estimated length of stay of less than 14 days
* Non-ambulatory status prior to admission (unable to walk \>50 meters)
* Pregnant
Source: ClinicalTrials.gov (NCT06637839). StuddyBuddy aggregates publicly available trial information.